
Viking Therapeutics sets $550 million stock offering price
SAN DIEGO - Viking Therapeutics, Inc. (NASDAQ: NASDAQ:VKTX), a biopharmaceutical company specializing in metabolic and endocrine disorders, has priced an underwritten public offering of 6,471,000 shares of common stock at $85.00 each. The transaction is expected to yield approximately $550 million before fees and expenses, with a closing date anticipated around March 4, 2024. The...